Sharon Yee

2.5k total citations
22 papers, 1.8k citations indexed

About

Sharon Yee is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Sharon Yee has authored 22 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Oncology. Recurrent topics in Sharon Yee's work include Cell death mechanisms and regulation (6 papers), RNA Interference and Gene Delivery (4 papers) and Angiogenesis and VEGF in Cancer (4 papers). Sharon Yee is often cited by papers focused on Cell death mechanisms and regulation (6 papers), RNA Interference and Gene Delivery (4 papers) and Angiogenesis and VEGF in Cancer (4 papers). Sharon Yee collaborates with scholars based in United States, France and Italy. Sharon Yee's co-authors include David A. Lawrence, Avi Ashkenazi, Robert Pitti, Klára Tótpál, Sarajane Ross, S.G. Hymowitz, Scot A. Marsters, Becky Yang, Klaus W. Wagner and Elizabeth A. Punnoose and has published in prestigious journals such as Nature Medicine, Blood and Molecular Cell.

In The Last Decade

Sharon Yee

22 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharon Yee United States 16 1.3k 635 515 302 295 22 1.8k
Christine Tan United States 10 1.2k 0.9× 487 0.8× 318 0.6× 272 0.9× 243 0.8× 17 1.9k
Andreas Menrad Germany 20 682 0.5× 513 0.8× 267 0.5× 280 0.9× 206 0.7× 30 1.5k
Pjotr Knyazev Germany 21 1.0k 0.8× 664 1.0× 742 1.4× 144 0.5× 226 0.8× 30 1.9k
Bruce E. Elliott Canada 26 1.1k 0.8× 584 0.9× 272 0.5× 102 0.3× 295 1.0× 62 1.9k
Junya Yoneda Japan 19 1.0k 0.8× 832 1.3× 257 0.5× 88 0.3× 562 1.9× 28 1.8k
Steve Coats United States 13 1.6k 1.2× 1.4k 2.3× 324 0.6× 137 0.5× 300 1.0× 18 2.3k
Bruno Alicke United States 21 1.8k 1.4× 566 0.9× 158 0.3× 101 0.3× 215 0.7× 32 2.3k
Barry A. Wolitzky United States 17 688 0.5× 296 0.5× 649 1.3× 166 0.5× 170 0.6× 22 1.6k
Habib Boukerche France 20 809 0.6× 504 0.8× 251 0.5× 106 0.4× 196 0.7× 33 1.6k
Peter D. Boasberg United States 21 761 0.6× 1.1k 1.7× 570 1.1× 110 0.4× 140 0.5× 44 1.7k

Countries citing papers authored by Sharon Yee

Since Specialization
Citations

This map shows the geographic impact of Sharon Yee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Yee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Yee more than expected).

Fields of papers citing papers by Sharon Yee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Yee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Yee. The network helps show where Sharon Yee may publish in the future.

Co-authorship network of co-authors of Sharon Yee

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Yee. A scholar is included among the top collaborators of Sharon Yee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Yee. Sharon Yee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Jintang, Shang‐Fan Yu, Sharon Yee, Surinder Kaur, & Keyang Xu. (2018). Characterization ofin vivobiotransformations for trastuzumab emtansine by high-resolution accurate-mass mass spectrometry. mAbs. 10(7). 1–8. 18 indexed citations
2.
Vollmar, Breanna S., BinQing Wei, Rachana Ohri, et al.. (2017). Attachment Site Cysteine Thiol pKa Is a Key Driver for Site-Dependent Stability of THIOMAB Antibody–Drug Conjugates. Bioconjugate Chemistry. 28(10). 2538–2548. 26 indexed citations
3.
Couch, Jessica A., Gu Zhang, Joseph C. Beyer, et al.. (2015). Balancing Efficacy and Safety of an Anti-DLL4 Antibody through Pharmacokinetic Modulation. Clinical Cancer Research. 22(6). 1469–1479. 20 indexed citations
4.
Junttila, Melissa R., Weiguang Mao, Xi Wang, et al.. (2015). Targeting LGR5 + cells with an antibody-drug conjugate for the treatment of colon cancer. Science Translational Medicine. 7(314). 314ra186–314ra186. 127 indexed citations
5.
Blackwood, Elizabeth, Jennifer Epler, Ivana Yen, et al.. (2013). Combination Drug Scheduling Defines a “Window of Opportunity” for Chemopotentiation of Gemcitabine by an Orally Bioavailable, Selective ChK1 Inhibitor, GNE-900. Molecular Cancer Therapeutics. 12(10). 1968–1980. 22 indexed citations
6.
Shi, Yunzhou, Jason Oeh, Jeffrey Eastham‐Anderson, et al.. (2013). Mapping In Vivo Tumor Oxygenation within Viable Tumor by 19F-MRI and Multispectral Analysis. Neoplasia. 15(11). 1241–IN1. 17 indexed citations
7.
Ogasawara, Annie, Jeff N. Tinianow, Alexander Vanderbilt, et al.. (2012). ImmunoPET imaging of phosphatidylserine in pro-apoptotic therapy treated tumor models. Nuclear Medicine and Biology. 40(1). 15–22. 18 indexed citations
8.
Gonzalvez, François, David A. Lawrence, Becky Yang, et al.. (2012). TRAF2 Sets a Threshold for Extrinsic Apoptosis by Tagging Caspase-8 with a Ubiquitin Shutoff Timer. Molecular Cell. 48(6). 888–899. 129 indexed citations
9.
Pacheco, Glenn, Calvin Ho, Sharon Yee, et al.. (2011). Vessel imaging with viable tumor analysis for quantification of tumor angiogenesis. Magnetic Resonance in Medicine. 65(3). 889–899. 11 indexed citations
10.
Wilson, Nicholas S., Becky Yang, Annie Yang, et al.. (2011). An Fcγ Receptor-Dependent Mechanism Drives Antibody-Mediated Target-Receptor Signaling in Cancer Cells. Cancer Cell. 19(1). 101–113. 213 indexed citations
11.
Pacheco, Glenn, Calvin Ho, Sharon Yee, et al.. (2010). Vessel imaging with viable tumor analysis for quantification of tumor angiogenesis. Magnetic Resonance in Medicine. 63(6). 1637–1647. 43 indexed citations
12.
Yee, Sharon, et al.. (2009). Post Radiotherapy Leiomyosarcoma of the Prostate: Can Radiation Therapy Induce a Secondary Cancer? A Case Report. UroToday International Journal. 2(3). 2 indexed citations
13.
Tótpál, Klára, David A. Lawrence, Scot A. Marsters, et al.. (2008). Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5. Cell Death and Differentiation. 15(4). 751–761. 120 indexed citations
14.
Foo, Dominic, et al.. (2008). Poster 314: Long Term Complications of Phrenic Nerve Pacemakers: A Case Study. Archives of Physical Medicine and Rehabilitation. 89(11). e125–e125. 1 indexed citations
15.
Daniel, Dylan, Becky Yang, Klára Tótpál, et al.. (2007). Activity of Apomab, a fully human agonistic DR5 monoclonal antibody, in models of non-Hodgkin’s lymphoma. Molecular Cancer Therapeutics. 6. 3 indexed citations
16.
Pan, Qi, Yvan H. Chanthery, Wei‐Ching Liang, et al.. (2007). Blocking Neuropilin-1 Function Has an Additive Effect with Anti-VEGF to Inhibit Tumor Growth. Cancer Cell. 11(1). 53–67. 425 indexed citations
17.
Wagner, Klaus W., Elizabeth A. Punnoose, Thomas Januario, et al.. (2007). Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. Nature Medicine. 13(9). 1070–1077. 487 indexed citations
18.
19.
20.
Yee, Sharon, et al.. (1993). Listeria-associated pericarditis in an AIDS patient.. PubMed. 85(3). 225–8. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Tan Breakdown of academic impact, for papers by Andreas Menrad Breakdown of academic impact, for papers by Pjotr Knyazev Breakdown of academic impact, for papers by Bruce E. Elliott Breakdown of academic impact, for papers by Junya Yoneda Breakdown of academic impact, for papers by Steve Coats Breakdown of academic impact, for papers by Bruno Alicke Breakdown of academic impact, for papers by Barry A. Wolitzky Breakdown of academic impact, for papers by Habib Boukerche Breakdown of academic impact, for papers by Peter D. Boasberg
Rankless by CCL
2026